Internally administered therapeutic agents for diseases in central and peripheral nervous system comprising mesenchymal cells as an active ingredient
First Claim
Patent Images
1. A cranial nerve disease therapeutic agent for in vivo administration, comprising a mesenchymal cell as an active ingredient.
3 Assignments
0 Petitions
Accused Products
Abstract
Intravenous administration of bone marrow cells collected from rat bone marrow to a rat cerebral infarction model was found to be effective in treating cerebral infarction. Human and murine bone marrow stem cells showed similar effects. Mesenchymal cells such as bone marrow cells, cord blood cells, or peripheral blood cells can be used as agents for in vivo administration against cranial nerve diseases.
-
Citations
13 Claims
- 1. A cranial nerve disease therapeutic agent for in vivo administration, comprising a mesenchymal cell as an active ingredient.
-
3. An agent for in vivo administration, exhibiting neuroprotection and comprising a mesenchymal cell as an active ingredient.
-
4. An agent for in vivo administration, exhibiting cranial nerve regeneration and comprising a mesenchymal cell as an active ingredient.
Specification